Cannabis Havn wants to turn hard lessons into psychedelic gold Many of the firm's well-known faces took lumps in the weed sector, mistakes they say set them up for success in psychedelics Nick LabaOctober 13, 2020
Health and Safety Could microdosing psychedelics help treat schizophrenia? Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can Michelle GamageSeptember 23, 2020
Culture Can you have a psychedelic trip off a videogame? SoundSelf is a 'technodelic' that has been shown to produce unitative states of consciousness and brain states similar to psilocybin Nick LabaJuly 14, 2020
Health and Safety Rritual hires cannabis clinician as president to expand medicinal focus Psychedelics and holistic products can help battle the mental health crisis, says Rritual president Dr. Mike Hart Michelle GamageJune 23, 2020
Psychedelics Numinus licensed by Health Canada to extract and research psilocybin Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company Michelle GamageJune 12, 2020
Medical and Pharmaceutical Canada could regulate psychedelic therapy within few years, bets company Numinus Wellness goes public on the prediction that regulation is coming Michelle GamageMay 22, 2020
Analysis Psychedelics are experiencing a renaissance, but don’t expect them to be legalized anytime soon Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say Michelle GamageMay 14, 2020
Canada First official call to decriminalize psychedelics in Canada to be heard later this year Sponsor MP Paul Manly says he will be presenting the petitioners' requests to the House once the signature period ends in August Nick LabaApril 30, 2020
Cannabis 2.0 Extractors and psychedelic prospectors featured at KCSA investor conference Earnings leader Valens was a highlight at the one-day virtual event Nick LabaApril 20, 2020
News Psychedelic conference weighs treatment efficacy against mainstream viability Medical and therapeutic benefits are clear even if scalability isn't Michelle GamageApril 16, 2020